Clinical Trials Logo

Filter by:
NCT ID: NCT05101707 Completed - Hemiplegia Clinical Trials

CIMT and taVNS for Hemiplegia in Infants

Start date: April 1, 2022
Phase: Early Phase 1
Study type: Interventional

Newborns who are born premature or suffer brain injury at birth are at risk for motor problems that may cause weakness in reaching and grasping on one side of the body. In older children, therapists may use a hand mitt and restraint for the stronger arm, to encourage use of the weaker side, called constraint-induced movement therapy (CIMT). Even with the high intensity therapy of CIMT, it typically takes between 40-120 hours total treatment time for most children to improve their motor skills. A non-invasive form of nerve stimulation, transcutaneous auricular vagus nerve stimulation (taVNS), stimulates a nerve by the ear that enhances learning motor skills. The purpose of this study is to evaluate the safety and effectiveness of taVNS to improve motor skills when paired with CIMT in infants with one-sided weakness at 6-18months of age.

NCT ID: NCT05101486 Completed - Clinical trials for Respiratory Syncytial Virus Prevention

A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years

Start date: November 1, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate non-inferiority in terms of humoral immune responses of Ad26.RSV.preF-based study vaccine lots representative of different aged vaccine in comparison to a non-aged Ad26.RSV.preF-based study vaccine lot.

NCT ID: NCT05101343 Completed - Healthy Clinical Trials

Use of Fitbits During Breathing Meditation

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This study will examine short breathing meditations paired with Fitbit technology in order to assess mindfulness and track physical activity. Measures including heart rate, physical activity, sleep patterns, as well as assessments of well-being and anxiety levels, will be examined.

NCT ID: NCT05101252 Completed - Visual Acuity Clinical Trials

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

Start date: October 11, 2021
Phase: N/A
Study type: Interventional

This is a single-masked, two-arm, parallel-group, randomized-controlled, dispensing clinical trial to evaluate the visual performance.

NCT ID: NCT05101122 Completed - Clinical trials for Obstructive Sleep Apnea

Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)

SEED
Start date: October 19, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The SEED study is designed to assess the safety and efficacy for Obstructive Sleep Apnea (OSA) of 3 escalating dose combinations of atomoxetine with AD313 compared to baseline and to atomoxetine alone.

NCT ID: NCT05101083 Completed - Hearing Loss Clinical Trials

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

This clinical investigation is designed to compare audiological performance (i.e., measurements of sound quality and speech understanding) between Starkey's new receiver-in-canal device and a commercially available legacy receiver-in-canal device.

NCT ID: NCT05101031 Completed - Clinical trials for Undifferentated Shock

Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)

Fresh-ER
Start date: December 18, 2020
Phase:
Study type: Observational

The objective of the study is to observe the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during rapid fluid bolus.

NCT ID: NCT05100979 Completed - Communication Clinical Trials

Patient-Clinician Communication Skill Training: A Mobile Education Initiative

Start date: October 24, 2022
Phase: N/A
Study type: Interventional

This study is a pilot test of The Art of Medicine Series, a smartphone-based educational tool to improve clinician-patient communication. Investigators will enroll clinicians (residents, fellows, attending physicians) and family caregivers (most often parents) from the Children's Wisconsin neonatal intensive care unit (NICU). Participants will then receive a series of links to short, animated videos sent to their phone by text message. Each video teaches best-practice communication techniques such as how patients can prompt teach back and how clinicians can avoid biased phrasing in delivering news. Over the 4-week intervention (the length of resident's rotation), clinicians will receive 15 videos and patients will receive 8 videos. Communication skills of clinicians and patients will be assessed pre and post intervention using validated measures and participants' engagement with the videos will be tracked with software in the website.

NCT ID: NCT05100589 Completed - Cognitive Change Clinical Trials

Effect of PeakATP on Mood, Reaction Time and Cognition

Start date: October 6, 2021
Phase: N/A
Study type: Interventional

Oral ATP disodium (adenosine 5'- triphosphate disodium) is a commercially available product available alone and as a constituent in a number of sports supplements that is purported to maintain ATP levels and improve performance during high-intensity exercise. Acute deficits in cognitive performance have also been reported in both young adults and children following high-intensity exercise; however, the effects of supplemental ATP on cognitive performance has not been studied. Goals: 1. To investigate the effect of ATP supplementation versus. placebo on mood, reaction time and cognitive performance before and after an acute bout of fatiguing exercise. 2. To investigate the effect of ATP supplementation versus. placebo on anaerobic performance.

NCT ID: NCT05100563 Completed - Clinical trials for Autism Spectrum Disorder

Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

Start date: October 1, 2018
Phase:
Study type: Observational

High dose naltrexone with response gauged by pain tolerance as measured by the cold pressor test may help treat autism.